Metrics
Publication
135
Open Access
11
UN Sustainable Development Goals
Education
2012 - 2014
2012 - 2014Post Doctorate of Medicine
University of Michigan, School of Medicine, Gastroenterology and Hepatology, United States Of America
2009 - 2012
2009 - 2012Post Doctorate of Medicine
Ege University, Faculty Of Medicine, Dahili Tıp Bilimleri Bölümü, Turkey
2002 - 2008
2002 - 2008Expertise In Medicine
Marmara University, School Of Medicine, Internal Medical Sciences, Turkey
1995 - 2001
1995 - 2001Undergraduate
Istanbul University, Cerrahpaşa Tıp Fakültesi, Cerrahpaşa Tıp Pr. (İngilizce), Turkey
Foreign Languages
C2 Mastery
C2 MasteryEnglish
Certificates, Courses and Trainings
2021
2021FBH Akademi Kongresi
Health&Medicine
Turkey
Research Areas
Health Sciences
Gastroenterology and Hepatology
Research Areas Based on Academic Activities
Avesis Research Areas
WoS Research Areas
Scopus Research Areas
Academic Positions
2016 - Continues
2016 - ContinuesAssociate Professor
Acibadem Mehmet Ali Aydinlar University, School Of Medicine, Department Of Medical Sciences
2015 - 2016
2015 - 2016Assistant Professor
Acibadem Mehmet Ali Aydinlar University, School Of Medicine, Department Of Medical Sciences
Non Academic Experience
2014 - Continues
2014 - ContinuesGastroenteroloji Uzmanı
Kadıköy Acıbadem Hastanesi, Gastroenteroloji Uzmanı
2017 - 2017
2017 - 2017Gozlemci Arastirma Gorevlisi
Academic Medical Center, Gozlemci Arastirma Gorevlisi
2012 - 2014
2012 - 2014Hepatoloji Klinik Araştırma Görevlisi
Michigan Üniversitesi, Gastroenteroloji ve Hepatoloji Bilim Dalı, Hepatoloji Klinik Araştırma Görevlisi
2008 - 2009
2008 - 2009Gastroenteroloji Yan Dal Asistanı
Haydarpaşa Numune Hastanesi Eğitim ve Araştırma Hastanesi, Gastroenteroloji Yan Dal Asistanı
Courses
Undergraduate
Undergraduate
Acute Viral Hepatitis
CURRENT MANAGEMENT OF VIRAL HEPATITIS
Biochemical Assessment of Liver Function Tests
Acute Liver Failure
Acute Liver Failure
Pankreas Hastaliklarinin Patofiyolojisi
Karaciger Hastaliklarinin Patofizyolojisi
Management of chronic viral hepatitis
Biochemical Assessment of Liver Function Tests
Gastroenterolojide Hikaye Alinmasi ve Fizik Muayene
GASTROENTEROLOJI’xxDE SIK GORULEN HASTALIKLAR
Gastroenteroloji Pratik Programi
Supervised Theses
2022
2022Expertise In Medicine
NON-İNVAZİF YÖNTEMLERLE BELİRLENEN HEPATOSTEATOZ ve KARACİĞER FİBROZİSİNİN HOSPİTALİZE COVİD-19 HASTALARININ PROGNOZUNA ETKİSİ
Tözün A. N. (Co-Advisor), Yapalı S.
B.ÇİÇEK(Student)
Articles
All (54)
SCI-E, SSCI, AHCI (36)
SCI-E, SSCI, AHCI, ESCI (41)
ESCI (2)
Scopus (40)
TRDizin (7)
Other Publications (9)
2026
20261. Efficacy and tolerability of tenofovir alafenamide fumarate prophylaxis in HBV-infected individuals receiving chemo/ immunosuppressive therapy
Dilber F., Durak S., Unsal Y., DEMİR M., Yildirim A. E., Ellik Z. M., et al.
Hepatology Forum
, vol.7, no.1, pp.26-31, 2026 (Scopus)
2025
20252. Long-Term Impact of COVID-19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities
Marasco G., Hod K., Colecchia L., Cremon C., Barbaro M. R., Cacciari G., et al.
United European Gastroenterology Journal
, vol.13, no.5, pp.798-818, 2025 (SCI-Expanded, Scopus)
2025
20253. Metabolic Dysfunction-Associated Steatotic Liver Disease in the MENA Region: Setting a Research and Action Priority Agenda.
El-Kassas M., Villota-Rivas M., Alswat K. A., AlNaamani K. M., Yilmaz Y., Labidi A., et al.
Liver international : official journal of the International Association for the Study of the Liver
, vol.45, no.6, 2025 (SCI-Expanded, Scopus)
2025
20254. Neural-Mediated Laryngopharyngeal Reflux Disease and the Role of Esophageal Dysmotility
YAPALI S., Bor S.
Otolaryngologic Clinics of North America
, vol.58, no.3, pp.451-463, 2025 (SCI-Expanded, Scopus)
2025
20255. Psychological and Clinical Factors Mediate Post-COVID-19 Irritable Bowel Syndrome
Hod K., Marasco G., Colecchia L., Cremon C., Barbaro M. R., Cacciari G., et al.
Neurogastroenterology and Motility
, 2025 (SCI-Expanded, Scopus)
2024
20246. Fatty Liver Disease: Understanding the New Terminology and Clinical Management
Yapali S.
The Turkish Journal of Current Gastroenterology , vol.25, pp.133-144, 2024 (Peer-Reviewed Journal)
2023
20237. Safety and Effectiveness of Tenofovir Alafenamide in the Turkish Population: A Systematic Review
TABAK Ö. F., YAPALI S., Celen M. K., GÜNER H. R.
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
, no.2, pp.43-51, 2023 (ESCI)
2023
20238. TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease.
Yilmaz Y., Zeybel M., Adali G., Cosar A. M., Sertesen E., Gokcan H., et al.
Hepatology forum
, vol.4, no.Suppl 1, pp.1-32, 2023 (ESCI, Scopus, TRDizin)
2023
20239. Post COVID-19 irritable bowel syndrome
Marasco G., Cremon C., Barbaro M. R., Cacciari G., Falangone F., Kagramanova A., et al.
GUT
, vol.72, no.3, pp.484-492, 2023 (SCI-Expanded, Scopus)
2022
202210. SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis
Efe C., Tascilar K., Gerussi A., Bolis F., Lammert C., Ebik B., et al.
JOURNAL OF AUTOIMMUNITY
, vol.132, 2022 (SCI-Expanded, Scopus)
2022
202211. Real life efficacy and tolerability of Tenofovir alafenamde fumarate in liver transplant recipients: a multicenter study
GÖKCAN H., YAPALI S., HARPUTLUOĞLU M. M. M., Ellik Z. M. L., Gokcen P., ADANIR H., et al.
JOURNAL OF HEPATOLOGY
, 2022 (SCI-Expanded, Scopus)
2022
202212. Preliminary results of the effectiveness and safety of Tenofovir Alefenamide Fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapy
Gunduz F., DURAK S., Unsal Y., Demir M., Ellik Z. M., Yildirim A. E., et al.
JOURNAL OF HEPATOLOGY
, 2022 (SCI-Expanded, Scopus)
2022
202213. Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study
Marasco G., Cremon C., Barbaro M. R., Salvi D., Cacciari G., Kagramanova A., et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY
, vol.117, no.1, pp.147-157, 2022 (SCI-Expanded, Scopus)
2021
202114. REAL LIFE EFFICACY AND TOLERABILITY OF TENOFOVIR ALAFENAMIDE FUMARATE IN PATIENTS WITH HEPATITIS B VIRUS-RELATED CIRRHOSIS AND LIVER TRANSPLANT RECIPIENTS. A-PRELIMINARY RESULT
YAPALI S., GÖKCAN H., Harputluoglu M., Ellik Z. M., AKARSU M., DURAK S., et al.
HEPATOLOGY
, vol.74, 2021 (SCI-Expanded, Scopus)
2021
202115. EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN HEPATITIS B VIRUS-INFECTED PATIENTS WITH CHRONIC HEMODIALYSIS AND RENAL TRANSPLANTATION: A PRELIMINARY RESULT
ADANIR H., Etik D. O., YILDIRIM A. E., Mehdiyev S., YAPALI S., COŞAR A. M., et al.
HEPATOLOGY
, vol.74, 2021 (SCI-Expanded, Scopus)
2021
202116. Long-term Kinetics of Alpha-fetoprotein in Chronic Hepatitis C Patients Treated with Direct-acting Antivirals and Possible Predictive Role of AFP Response to Treatment on Development of Hepatocellular Carcinoma
Ulasoglu C., Senates B. E., YAPALI S., Dumanoglu B., Enc F., ÇOLAK Y., et al.
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
, vol.27, no.2, pp.49-52, 2021 (Peer-Reviewed Journal)
2021
202117. Sistemik Hastalıklar ve Karaciğerin Nodüler Rejeneratif Hiperplazisi
Yapali S.
Türkiye Klinikleri Gastroenterohepatoloji Dergisi , vol.14, no.2, pp.104-110, 2021 (TRDizin)
2021
202118. Gebeliğin Akut Yağlı Karaciğeri
Yapali S.
Türkiye Klinikleri Gastroenterohepatoloji Dergisi , vol.14, no.2, pp.42-48, 2021 (TRDizin)
2020
202019. Real-world efficacy and safety of Ledipasvir plus Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir +/- Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience
Degertekin B., DEMİR M., AKARCA U. S., KANİ H. T., ÜÇBİLEK E., Yildirim E., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, vol.31, no.12, pp.883-893, 2020 (SCI-Expanded, Scopus, TRDizin)
2020
202020. Regular coffee intake improves liver enzyme levels and liver histology in patients with chronic alcohol consumption, non-alcoholic fatty liver and non-alcoholic steatohepatitis: Report of 259 cases
DEĞERTEKİN M. B., TÖZÜN A. N., Söylemez A. G., Gurtay E., Bozkurt U., YILMAZ Y., et al.
Hepatology Forum
, vol.1, no.3, pp.88-96, 2020 (Peer-Reviewed Journal)
2020
202021. What hepatologists need to know about COVID-19?
Yapali S.
Hepatology forum
, vol.1, no.2, pp.41-43, 2020 (Scopus)
2020
202022. Determination of the upper limits of normal serum alanine aminotransferase (ALT) level in healthy Turkish population.
Degertekin B., Tozun N., Demir F., Soylemez G., Yapali S., Bozkurt U., et al.
Hepatology forum
, vol.1, no.2, pp.44-47, 2020 (Peer-Reviewed Journal)
2020
202023. Determination of the upper limits of normal serum alanine aminotransferase (ALT) level in healthy Turkish population
Değertekin M. B., Tözün A. N., Demir F., Soylemez G., Yapalı S., Bozkurt U., et al.
Hepatology Forum , vol.1, no.2, pp.44-47, 2020 (Peer-Reviewed Journal)
2019
201924. Dealing with the gray zones in the management of gastric cancer: The consensus statement of the Istanbul Group
AYTAÇ E., Aslan F., ÇİÇEK B., Erdamar S., Gurses B., GÜVEN K., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, vol.30, no.7, pp.584-598, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201925. Noninvasive Tests in Nonalcoholic Fatty Liver Disease
Yapalı S.
Türkiye Klinikleri , vol.1, pp.35-40, 2019 (Peer-Reviewed Journal)
2019
201926. Covering the Cover
Yapalı S.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, vol.30, no.7, pp.582-583, 2019 (SCI-Expanded)
2018
201827. The Role of New Viral Biomarkers in Chronic Hepatitis B: Ready to Use in the Clinical Practice?
Yapali S.
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
, vol.24, no.2, pp.57-60, 2018 (Peer-Reviewed Journal)
2018
201828. High-resolution esophageal manometry: Evaluation of differences between supine and lateral recumbent positions
Palmela C., Oors J. M., Hillenius S., YAPALI S., de Rooij W., Smout A. J. P. M., et al.
NEUROGASTROENTEROLOGY AND MOTILITY
, 2018 (SCI-Expanded, Scopus)
2018
201829. COVERING THE COVER.
Yapalı S.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, vol.29, pp.375-376, 2018 (SCI-Expanded, Scopus, TRDizin)
2018
201830. Epidemiology and viral risk factors for hepatocellular carcinoma in the Eastern Mediterranean countries
Yapalı S., Tözün A. N.
Hepatoma Resarch , vol.4, no.24, pp.1-10, 2018 (Peer-Reviewed Journal)
2017
201731. Seroprevalance of hepatitis B and C infections in Turkey.
Yapali S.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, vol.28, no.2, pp.147-148, 2017 (SCI-Expanded, Scopus, TRDizin)
2016
201632. Admissions for hepatitis B reactivation in patients receiving immunosuppressive therapy remain unchanged from 1999 to 2014.
Patel A., Yapali S., Lok A.
Hepatology international
, vol.10, pp.139-46, 2016 (SCI-Expanded, Scopus)
2016
201633. New treatments for chronic hepatitis C infection
Yapali S., Tozun N.
MARMARA MEDICAL JOURNAL
, vol.29, pp.43-49, 2016 (Peer-Reviewed Journal)
2015
201534. Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy
TURAN İ., YAPALI S., Bademkiran F., KÖSE T., DUMAN S., Sozbilen M., et al.
LIVER TRANSPLANTATION
, vol.21, no.8, pp.1066-1075, 2015 (SCI-Expanded, Scopus)
2015
201535. Changes in characteristics of hepatitis C patients seen in a liver centre in the United States during the last decade.
Talaat N., Yapali S., Fontana R., Conjeevaram H., Lok A.
Journal of viral hepatitis
, vol.22, pp.481-8, 2015 (SCI-Expanded, Scopus)
2015
201536. TLR2 and TLR4 gene expression levels and associated factors during acute attack and attack-free periods in familial Mediterranean fever
Karakose M. Z., YAPALI S., Salman E., Aksu K., Karakose S., AKARCA U. S.
CLINICAL RHEUMATOLOGY
, vol.34, no.4, pp.785-790, 2015 (SCI-Expanded, Scopus)
2015
201537. 7 günlük standard üçlü tedaviye C ve E vitamini eklenmesiHelikobakter pilori eradikasyon oranını arttırır
GÜZELBULUT F., SEZiKLi M., ÇETiNKAYA Z. A., YAPALI S., İNCE A. T., ÖVÜNÇ O.
Akademik Gastroenteroloji , vol.9, no.2, pp.60-63, 2015 (Peer-Reviewed Journal)
2015
201538. Outcomes of patients with chronic hepatitis B who do not meet criteria for antiviral treatment at presentation.
Yapali S., Talaat N., Fontana R., Oberhelman K., Lok A.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
, vol.13, 2015 (SCI-Expanded, Scopus)
2014
201439. Does suppression of HBV replication by antiviral therapy confer the same benefit as host immune control of HBV?
Yapali S., Lok A.
Gut
, vol.63, pp.1833-4, 2014 (SCI-Expanded, Scopus)
2014
201440. Sexual activity does not predispose to reflux episodes in patients with gastroesophageal reflux disease
BOR S., Valytova E., YAPALI S., Yildirim E., VARDAR R.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL
, vol.2, no.6, pp.482-489, 2014 (SCI-Expanded, Scopus)
2014
201441. Systematic review: identifying patients with chronic hepatitis C in need of early treatment and intensive monitoring--predictors and predictive models of disease progression.
Konerman M., Yapali S., Lok A.
Alimentary pharmacology & therapeutics
, vol.40, pp.863-79, 2014 (SCI-Expanded, Scopus)
2014
201442. A severe case of esophageal ulcer causing a tight stricture despite long-term D-penicillamine treatment
YAPALI S., TURAN İ., Ozutemiz O., Tekesin O.
WIENER KLINISCHE WOCHENSCHRIFT
, vol.126, no.23-24, pp.789-791, 2014 (SCI-Expanded, Scopus)
2014
201443. Potential benefit of telbivudine on renal function does not outweigh its high rate of antiviral drug resistance and other adverse effects.
Yapali S., Lok A.
Gastroenterology
, vol.146, pp.15-9, 2014 (SCI-Expanded, Scopus)
2014
201444. Management of hepatitis B: our practice and how it relates to the guidelines.
Yapali S., Talaat N., Lok A.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
, vol.12, pp.16-26, 2014 (SCI-Expanded, Scopus)
2013
201345. Should treatment of hepatitis B patients be based solely on liver fibrosis?
Yapali S., Lok A.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
, vol.11, pp.1500-2, 2013 (SCI-Expanded, Scopus)
2013
201346. Should this patient be treated Best practices in identifying cirrhosis and HCC in patients infected with HBV Role of prediction models
YAPALI S., LOK A. S.
Johns Hopkins Medicine eViralHepatitis Review , vol.3, no.3, pp.1-12, 2013 (Peer-Reviewed Journal)
2013
201347. Giant esophageal lipoma presenting with gastroesophageal reflux symptoms.
Yapali S., Oruc N., Harman M., Aydin A.
Journal of gastrointestinal and liver diseases : JGLD
, vol.22, pp.8, 2013 (SCI-Expanded, Scopus)
2013
201348. Frontal Skull Metastasis Extending Through the Scalp: Initial Sign of Hepatocellular Carcinoma Recurrence 5 Years After Liver Transplantation
TURAN İ., YAPALI S., Ozutemiz O., KARASU A. Z.
TRANSPLANTATION
, vol.95, no.3, 2013 (SCI-Expanded, Scopus)
2013
201349. The role of Bernstein test with pH-impedance monitoring in different subtypes of GERD: Re-evaluation of an old technique
YAPALI S., Vardar R., Yildirim E., BOR S.
JOURNAL OF CLINICAL GASTROENTEROLOGY
, vol.47, no.1, pp.96-97, 2013 (SCI-Expanded, Scopus)
2012
201250. Acute presentation of autoimmune hepatitis in a patient with myasthenia gravis, thymoma, Hashimoto thyroiditis and connective tissue disorder
Yapali S., ORUÇ N., Ilgun S., YILMAZ F., AKSU K., Yilmaz M., et al.
Hepatology Research
, vol.42, no.8, pp.835-839, 2012 (SCI-Expanded, Scopus)
2011
201151. Literatürden Seçmeler Helicobakter pilori enfeksiyonu ve özofagus hastalıkları
YAPALI S.
Skop Gastrointestinal Endoskopi Dergisi , no.5, pp.45-47, 2011 (Non Peer-Reviewed Journal)
2009
200952. Serum Levels of Adipokines in Patients with Chronic HCV Infection: Relationship with Steatosis and Fibrosis
TIFTIKCI A., ATUĞ Ö., YILMAZ Y., EREN F., Ozdemir F. T., Yapali S., et al.
ARCHIVES OF MEDICAL RESEARCH
, vol.40, no.4, pp.294-298, 2009 (SCI-Expanded, Scopus)
2008
200853. Is there a role for adipocytokines on the effect of anti-TNF treatment in an experimental model of colitis?
Yapali S., Deniz M., Eren F., Imeryuz N., Celikel C., Ozkan N., et al.
GASTROENTEROLOGY
, vol.134, no.4, 2008 (SCI-Expanded, Scopus)
2007
200754. Anti-TNF treatment in inflammatory bowel disease
Yapali S., Hamzaoglu H. O.
Annals of Gastroenterology
, vol.20, no.1, pp.48-53, 2007 (SCI-Expanded)
Papers Presented at Peer-Reviewed Scientific Conferences
2022
20221. Real life efficacy and tolerability of tenofovir alafenamde fumarate in liver transplant recipients: a multicenter study
YAPALI S., GÖKCAN H., HARPUTLUOĞLU M. M. M., Ellik Z. M., Gokcen P., ADANIR H., et al.
Joint Annual International Congress of ILTS, ELITA and LICAGE, İstanbul, Turkey, 4 - 07 May 2022, pp.107-108, (Summary Text)
2022
20222. Real life efficacy and tolerability of Tenofovir Alafenamide Fumarate in patients with hepatitis-B virus-related cirrhosis
YAPALI S., GÖKCAN H., Durak S., Ellik Z. M., Guzelbulut F., Vatansever S., et al.
International Liver Congress, London, Canada, 22 - 26 June 2022, (Summary Text)
2021
20213. EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN HEPATITIS B VIRUS-INFECTED PATIENTS WITH CHRONIC HEMODIALYSIS AND RENAL TRANSPLANTATION: A PRELIMINARY RESULT
Yapali S.
AASLD THE LIVER MEETİNG DIGITAL EXPERIENCE, 12 - 15 November 2021, vol.74, pp.480-481, (Summary Text)
2021
20214. REAL LIFE EFFICACY AND TOLERABILITY OF TENOFOVIR ALAFENAMIDE FUMARATE IN PATIENTS WITH HEPATITIS B VIRUS-RELATED CIRRHOSIS AND LIVER TRANSPLANT RECIPIENTS. A-PRELIMINARY RESULT
Yapali S.
The Liver Meeting Digital Experience-AASLD, Washington, United States Of America, 12 - 15 November 2021, vol.74, pp.490-491, (Summary Text)
2021
20215. REAL-LIFE EFFICACY and TOLERABILITY OF TENOFOVIR ALAFENAMIDE IN SPECIAL GROUPS OF HEPATITIS B PATIENTS: LIVER TRANSPLANT RECIPIENTS AND CIRRHOSIS
Yapalı S.
AASLD_TASL Digital Hepatology Connect, 15 January 2021, pp.2-3, (Full Text)
2021
20216. EFFECT OF TENOFOVIR ALAFENAMIDE FUMARATE (TAF) PROPHYLAXIS FOR HEPATITIS B VIRUS REACTIVATION IN HBV-INFECTED INDIVIDUALS, WHO RECEIVED CHEMO/IMMUNOSUPPRESSIVE THERAPY
Yapalı S.
AASLD_TASL Digital Hepatology Connect, 15 - 16 January 2021, pp.3-4, (Full Text)
2021
20217. EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN CHRONIC HEPATITIS B PATIENTS WITH CHRONIC HEMODIALYSIS AND KIDNEY TRANSPLANTATION‐ REALITY STUDY
Yapalı S.
AASLD-TASL Hepatology Connect, 15 - 16 January 2021, pp.1-2, (Full Text)
2019
20198. "Hipereozinofilik sendrom benzeri klinik ile prezente olan ilaca bağlı akut karaciğer hasarı”
Yapalı S., Yucel S., Sariguzel N., Küçükmetin N., Saruc M., Ünal H. U., et al.
12. Ulusal Hepatoloji Kongresi, Antalya, Turkey, 1 - 05 May 2019, pp.16, (Full Text)
2019
20199. Esophageal high resolution manometry (ESO HRM) results in gastroesophageal reflux (GER) patientsPP352
Tiftikci A., ERSOY Ö., VARDARELİ N. E., Yapali S., kızıltaş ş., Onder O., et al.
World Congress of gastroenterology, İstanbul, Turkey, 21 - 24 September 2019, (Summary Text)
2019
201910. Sepsis hastalarında gelişen karaciğer işlev bozukluğu ve mortaliteyi etkileyen faktörler
rustamova n., Onder O., BAHŞİ Ş., ÇAKAR N., Yapali S., Turkel K. N., et al.
12.Ulusal hepatoloji Kongresi, Antalya, Turkey, 1 - 05 May 2019, (Summary Text)
2019
201911. Case Report: Drug-induced liver injury mimicking hypereosinophilic syndrome
Yapalı S., Yucel S., Sariguzel N., Saruc M., Unal H. U., Tıftıkcı A., et al.
AASLD-TASL Connect Meeting , İstanbul, Turkey, 15 - 16 March 2019, pp.34, (Summary Text)
2017
201712. IS TELBIVUDINE-INDUCED POLYNEUROPATHY/MYOPATHY REVERSIBLE IN LIVER TRANSPLANT RECIPIENTS?
TURAN İ., YAPALI S., BADEMKIRAN F., GÜNŞAR F., ZEYTUNLU M., ERSÖZ G., et al.
34. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 1 - 06 December 2017, (Summary Text)
2017
201713. Is Telbivudine-Induced Polyneuropathy/Myopathy Reversible in Liver Transplant Recipients?
TURAN İ., YAPALI S., GÜNŞAR F., ZEYTUNLU M., ERSÖZ G., AKARCA U. S., et al.
The Liver Meeting AASLD 2017, Washington DC, USA, 20 - 24 October 2017, vol.66, (Summary Text)
2017
201714. Is Telbivudine-Induced Polyneuropathy/Myopathy Reversible in Liver Transplant Recipients?
TURAN İ., YAPALI S., GÜNŞAR F., ZEYTÜNLÜ M., ERSÖZ G., AKARCA U. S., et al.
68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Washington, Kiribati, 20 - 24 October 2017, vol.66, (Summary Text)
2017
201715. Adenoma Detection Rate Varies Greatly Among Different Centers of the Same Health Group (Analyzes of 28.000 Colonoscopies Performed in 14 Centers)
Vardareli E. K., Kucukmetin N. T., Ersoy Ö., Yapali S., Degertekin B., Tiftikci A., et al.
Digestive Disease Week, Illinois, United States Of America, 6 - 09 May 2017, vol.85, (Summary Text)
2016
201616. Reversal of Renal Improvement After Discontinuation of Telbivudine in Liver Transplant Recipients
TURAN İ., YAPALI S., Gunsar F., KÖSE T., Sozbilen M., AKARCA U. S., et al.
22nd Annual International Congress of the International-Liver-Transplantation-Society (ILTS), Seoul, South Korea, 4 - 07 May 2016, (Summary Text)
2015
201517. Postgraduate Course Case Presentations Noncardiac Chest Pain
YAPALI S., BOR S., FOX M.
UEG Week 2015, Barcelona, Spain, 24 - 28 October 2015
2015
201518. Conversion from Sirolimus to Everolimus in the Maintenance Treatment of Liver Transplant Recipients: Preliminary Results of a 1-Year Study
TURAN İ., YAPALI S., KARASU A. Z., Sozbilen M., AKARCA U. S., Ersoz G., et al.
66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Costa Rica, 13 - 17 November 2015, (Summary Text)
2015
201519. KRONIK HEPATIT B Tedavide Yeni Neler Var
YAPALI S.
10. Ulusal Hepatoloji Kongresi, İstanbul, Turkey, 27 - 30 May 2015
2015
201520. Üst GİS endoskopisi kime ne zaman
YAPALI S.
Namık Kemal Menteş Ege Gastroenteroloji Günleri, İzmir, Turkey, 27 - 28 February 2015
2014
201421. BARSAK VE KARACİĞER İLİŞKİSİ AŞK MI NEFRET Mİ Araya Beyni de Koyalım Gut Liver Brain Axis
YAPALI S.
Ulusal Gastroenteroloji Haftasi, Antalya, Turkey, 26 - 30 November 2014
2014
201422. Identifying patients with chronic hepatitis C in need of early treatment and intensive monitoring A systematic review of predictors and predictive models of disease progression
KONERMAN M., YAPALI S., LOK A. S.
The Liver Meeting 2014 (AASLD), BOSTON, United States Of America, 7 - 11 November 2014, vol.60, pp.938-939
2014
201423. Outcome of chronic hepatitis B patients who discontinued nucleos t ide analogue therapy
YAPALI S., OBERHELMAN K., LOK A. S.
The Liver Meeting 2014 (AASLD), Boston, United States Of America, 7 - 11 November 2014, vol.60, pp.1114-1115
2004
200424. Inflamatuar barsak hastalığında fertilite gebelik emzirme dönemi ve cinsel yaşam
YAPALI S., KEFELİ U., TAHAN V., BARGHI I., ATUĞ Ö., İMERYÜZ N., et al.
21. Ulusal Gastroenteroloji Haftasi, Turkey, 31 August - 05 September 2004, vol.15, pp.27
2014
201425. Su1011 Outcome of Chronic Hepatitis B Patients Who Do Not Meet Criteria for Antiviral Treatment At Presentation
YAPALI S., TALAAT N., ROBERT J F., CONJEEVARAM H., OBERHELMAN K., LOK A. S.
GASTROENTEROLOGY (DDW), Chicago, United States Of America, 1 - 31 May 2014, vol.146, pp.962
2014
201426. Outcome of Chronic Hepatitis B Patients Who Do Not Meet Criteria for Antiviral Treatment At Presentation
YAPALI S., Talaat N., Fontana R. J., Conjeevaram H., Oberhelman K., Lok A. S.
55th Annual Meeting of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / Digestive Disease Week (DDW), Illinois, United States Of America, 3 - 06 May 2014, (Summary Text)
2014
201427. P011 The impact of omentectomy on the severity of colitis and adipocytokine expression
YAPALI S., ORUÇ N., YENİSEY Ç., SEZAK M., ÇERİ N. G., ÖZÜTEMİZ A. Ö.
JOURNAL OF CROHN'S AND COLITIS, 1 - 28 February 2014, vol.8, pp.69
2013
201328. Changes in characteristics of hepatitis C HCV patients referred to liver centers in the United States US in the past decade
TALAAT N., YAPALI S., FONTANA R. J., CONJEEVARAM H., ASKARI F. K., LOK A. S.
The Liver Meeting 2013 (AASLD), Washington, Kiribati, 1 - 05 November 2013, vol.58, pp.911
2013
201329. Comparison of cortical responses by functional magnetic resonance inaging fMRI in patients with erosive reflux disease and nonerosive reflux disease
YAPALI S., VARDAR R., ÇALLI M. C., YILDIRIM E., BOR S.
UEG Week 2013, Berlin, Germany, 12 - 16 October 2013, vol.1, pp.111
2013
201330. Solitary rectal ulcer syndrome The role of anorectal physiology tests in refractory cases
ÖZKÜTÜK N., VARDAR R., ÜNAL N. G., YAPALI S., TURASAN E., BOR S.
UEG Week 2013, Berlin, Germany, 12 - 16 October 2013, vol.1
2013
201331. Özofagusta Crohn Hastalığı
YAMAN M., VARDAR R., ORUÇ N., YAPALI S., ÖZÜTEMİZ A. Ö., BOR S.
30. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 11 - 15 September 2013, pp.137-138
2013
201332. Erozif ve nonerozif reflu hastalıgında kortikal aktivitenin fonksiyonel magnetik rezonans fMRI ile degerlendirilmesi
YAPALI S., VARDAR R., ÇALLI M. C., YILDIRIM E., BOR S.
30. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 11 - 15 September 2013, pp.23
2011
201133. Kronik hepatit B infeksiyonunda HBsAg kaybı sonrası prognoz
YAPALI S., GÜNŞAR F., KARASU A. Z., ERSÖZ G., AKARCA U. S.
8. Ulusal Hepatoloji Kongresi, Ankara, Turkey, 1 - 05 June 2011, pp.234
2012
201234. The role of Bernstein test with pH impedance monitoring in different subtypes of gastroesophageal reflux disease Re evaluation of an old technique
YAPALI S., VARDAR R., YILDIRIM E., BOR S.
OESO CONGRESS, Como, Italy, 1 - 04 September 2012, vol.47, pp.96-97
2011
201135. Alkol dışı yağlı karaciğer hastalığında karaciğerde COX 2 ekspresyonu ile steatohepatit skoru ve fibrozis ilişkisi
ULKUDEN B., YILMAZ BARBET F., YAPALI S., ÜNAL N. G., GÜNŞAR F., VARDAR R., et al.
8. Ulusal Hepatoloji Kongresi, Ankara, Turkey, 1 - 05 June 2011, pp.253
2012
201236. Fonksiyonel Konstipasyonlu Olgularda Yaşam Kalitesi
ÖZKÜTÜK N., VARDAR R., ÜNAL N. G., YAPALI S., TURASAN E., BOR S.
29. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 20 - 25 November 2012
2012
201237. Gastroozofageal Reflu Hastaligi Alt Gruplarinda Bernstein Testi ile Asit Duyarliliginin ve Interseluler Araliktaki Genislemenin Degerlendirilmesi
YAPALI S., VARDAR R., YILDIRIM E., DOĞANAVŞARGİL YAKUT B., BOR S.
29. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 20 - 25 November 2012
2012
201238. Soliter rektal ülser sendromu Anorektal fizyoloji testleri ne kadar yardimci
ÖZKÜTÜK N., VARDAR R., ÜNAL N. G., YAPALI S., TURASAN E., BOR S.
29. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 20 - 25 November 2012
2012
201239. Uzun sureli D penisilamin tedavisi alan Wilson Hastalıgı olgusunda refrakter peptik striktur
YAPALI S., TURAN İ., ÖZÜTEMİZ A. Ö., TEKEŞİN O.
29. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 20 - 25 November 2012
2012
201240. Gastroözofageal reflü hastalığında intraözofageal impedans baseline değerleri Özofageal makroskopik ve mikroskopik hasarı gösterir mi
VARDAR R., YAPALI S., BAYRAKCI B., DOĞANAVŞARGİL YAKUT B., YILDIRIM E., BOR S.
29. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 20 - 25 November 2012
2012
201241. 492 IL28B GENOTYPE HAS NO IMPACT ON SPONTANEOUS HEPATITIS B SURFACE ANTIGEN HBSAG CLEARANCE IN INACTIVE CARRIERS A LONG TERM CASE MATCHED RETROSPECTIVE COHORT STUDY
YAPALI S., ÇETINTAŞ A., SALMAN E., GÜNŞAR F., ORUÇ N., VARDAR R., et al.
JOURNAL OF HEPATOLOGY, Berlin, Germany, 1 - 30 April 2012, vol.56, pp.193
2011
201142. Otoimmun hepatit olgularımızda takip ve tedavi ile iliskili faktorler
YAPALI S., GÜNŞAR F., GURSEL B., ERSÖZ G., YILMAZ BARBET F., KARASU A. Z., et al.
28. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 16 - 20 November 2011, vol.22, pp.92-93
2011
201143. Fekal inkontinans tedavisinde egzersiz Anorektal fizyoloji inkontinans sıklıgı ve yasam kalitesi uzerine etkisi
YAPALI S., KAYAR E., VARDAR R., ÖZKÜTÜK N., BOR S.
28. Ulusal Gastroenteroloji Haftası, Turkey, 16 - 20 November 2011, vol.22, pp.5
2011
201144. Otoimmun hepatit olgularımızın klinik takip ve tedavi ozellikleri
GURSEL B., YAPALI S., ERSÖZ G., YILMAZ BARBET F., KARASU A. Z., ORUÇ N., et al.
28. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 16 - 20 November 2011, vol.22, pp.221
2011
201145. Laringofaringeal reflu semptomlu olgularda laparoskopik anti reflu operasyonunun laringeal bulgulara etkisi
VARDAR R., ŞAHiN M., YAPALI S., BOR S.
28. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 16 - 20 November 2011, vol.22, pp.125
2011
201146. Reflü semptomları ile prezente olan dev özofagus lipomu olgusu
YAPALI S., ORUÇ N., AYDIN A.
28. Ulusal Gastroenteroloji Haftası, Turkey, 16 - 20 November 2011, vol.22
2011
201147. Role of functional MRI in subtypes of gastroesophageal reflux disease
YAPALI S., BOR S.
European Bridging Meeting, Berlin, Germany, 10 - 12 November 2011
2006
200648. Allergic Rhinitis and Other Atopic Symptoms in Asthmatic Population in Turkey
CEYHAN B., YILDIRIM F., YAPALI S., EMEL E.
The American College of Allergy, Asthma and Immunology Annual Meeting, Philedelphia, United States Of America, 9 - 15 April 2006
2011
201149. Prognosis and predictor factors of anti HBs seroconversion following HBsAg seroclearance in hepatitis B infection
YAPALI S., VARDAR R., GÜNŞAR F., ERSÖZ G., KARASU A. Z., AKARCA U. S.
The Liver Meeting 2011 (AASLD), United States Of America, 4 - 08 November 2011, vol.54, pp.613
2010
201050. Myastenia gravis timoma Hashimoto tiroiditi ve bag dokusu hastalıgı olan olguda otoimmun hepatitin akut prezentasyonu
YAPALI S., ORUÇ N., ILGUN S., YILMAZ BARBET F., AKSU K., YILMAZ M., et al.
27. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 24 - 28 November 2010, vol.21, pp.299
2011
201151. Metabolik faktorler hepatit B yuzey antijen HBsAg kaybında etkili midir
YAPALI S., VARDAR R., GÜNŞAR F., ERSÖZ G., KARASU A. Z., ORUÇ N., et al.
8. Ulusal Hepatoloji Kongresi, Ankara, Turkey, 1 - 05 June 2011, pp.236
2011
201152. Hepatit B yüzey antijen kaybi HBsAg kaybı oluşan olgularda anti HBs serokonversiyonu ile iliskili faktörler
YAPALI S., VARDAR R., GÜNŞAR F., ORUÇ N., ÖZÜTEMİZ A. Ö., ERSÖZ G., et al.
8. Ulusal Hepatoloji Kongresi, Ankara, Turkey, 1 - 05 June 2011, pp.336
2011
201153. Hepatit B yuzey antijen HBsAg kaybı ve anne babada hepatit B oykusu iliskisi
YAPALI S., VARDAR R., GÜNŞAR F., ORUÇ N., ÖZÜTEMİZ A. Ö., ERSÖZ G., et al.
8. Ulusal Hepatoloji Kongresi, Ankara, Turkey, 1 - 05 June 2011, pp.237
2011
201154. Kronik hepatit B infeksiyonunda hepatit B yuzey antijeni HBsAg kaybı ile iliskili faktorler
YAPALI S., BAYRAKCI B., GÜNŞAR F., ERSÖZ G., KARASU A. Z., AKARCA U. S.
8. Ulusal Hepatoloji Kongresi, Ankara, Turkey, 1 - 05 June 2011, pp.83-84
2011
201155. Kronik hepatit B infeksiyonunda HCV koinfeksiyonu HBsAg kaybını Delta koinfeksiyonundan daha cok arttırmaktadır
YAPALI S., BAYRAKCI B., GÜNŞAR F., ERSÖZ G., KARASU A. Z., AKARCA U. S.
8. Ulusal Hepatoloji Kongresi, Ankara, Turkey, 1 - 05 June 2011, pp.22-23
2011
201156. Inaktif hepatit B infeksiyonunda HBsAg kaybı ile IL28B gen polimorfizmi iliskisi
YAPALI S., CETINTAS A., SALMAN E., GÜNŞAR F., KARASU A. Z., ERSÖZ G., et al.
8. Ulusal Hepatoloji Kongresi, Ankara, Turkey, 1 - 05 June 2011, pp.235
2011
201157. 399 DELTA VIRUS COINFECTION DOES NOT INCREASE BUT HCV COINFECTION INCREASE THE HBSAG LOSS IN CHRONIC HBV INFECTION
YAPALI S., BAYRAKÇI B., GÜNŞAR F., ERSÖZ G., KARASU A. Z., AKARCA U. S.
JOURNAL OF HEPATOLOGY, 1 - 31 March 2011
2010
201058. Ulseratif proktitte nuks gelisimini etkileyen fakttorler
YAPALI S., OSMANOGLU N., AKARCA U. S.
26. Ulusal Gastroenteroloji Haftası, Turkey, 24 - 28 November 2010, vol.21, pp.150
2010
201059. Ege UTF Gastroozofageal reflu merkezinin 6 yıllık sonucları
BOR S., YAPALI S., BAYRAKÇI B., YILDIRIM E., ÜNAL N. G., VARDAR R.
27. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 24 - 28 November 2010, vol.21
2010
201060. Deneysel kolit modelinde omentektominin inflamasyon üzerine etkisi
YAPALI S., ORUÇ N., YENİSEY Ç., SEZAK M., ÇERİ N. G., ÖZÜTEMİZ A. Ö.
27. Ulusal Gastroenteroloji Haftası, Antalya, Turkey, 24 - 28 November 2010, vol.21, pp.17
2010
201061. 737 HEPATITIS B SURFACE ANTIGEN SEROCLEARANCE RATES AND ASSOCIATED FACTORS IN CHRONIC HEPATITIS B INFECTION
YAPALI S., BAYRAKÇI B., AKYILDIZ M., VARDAR R., GÜNŞAR F., ERSÖZ G., et al.
JOURNAL OF HEPATOLOGY, 1 - 30 April 2010, vol.52, pp.287
2009
200962. Tanısal laparoskopi sonuçlarımız
ÖZTÜRK A., KIRDÖK S., BAYRAKÇI B., ÜNAL N. G., YAPALI S., ERGiN E., et al.
26. Ulusal Gastroenteroloji Haftası, Ankara, Turkey, 14 - 18 October 2009, vol.20
2009
200963. Wilson hastalığı olan hastalarımızın genel değerlendirilmesi
KUZU N., GÜNŞAR F., YAPALI S., AKYILDIZ M., BAYRAKÇI B., KARASU A. Z., et al.
26. Ulusal Gastroenteroloji Haftası, Ankara, Turkey, 14 - 18 October 2009, vol.20, pp.83
2009
200964. Eritropoietik protoporfirya EPP Transaminaz yüksekliği ve hiperbilirubinemi nedeni
ERGiN E., VARDAR R., ZENGİN M., OZTURK A., NART D., YAPALI S., et al.
26. Ulusal Gastroenteroloji Haftası, Ankara, Turkey, 14 - 18 October 2009, vol.20
2009
200965. Helikobakter pilori pozitif non ülser dispepsili hastalarda standart üçlü tedavi rejimi ile levofloksasin bazli üçlü tedavi rejiminin eradikasyon oranları karşılaştırılması
YAŞAR B., ŞENATEŞ E., COŞKUN S., ALTINÖZ E., YAPALI S., SEZiKLi M., et al.
26. Ulusal Gastroenteroloji Haftası, Ankara, Turkey, 14 - 18 October 2009, vol.20, pp.23
2009
200966. 7 günlük standart üçlü tedaviye C ve E vitamini eklemek tedavi başarısını arttirır mı
SEZiKLi M., AKKAN ÇETiNKAYA Z., GÜZELBULUT F., YAPALI S., YAŞAR B., İNCE A. T., et al.
26. Ulusal Gastroenteroloji Haftası, Ankara, Turkey, 14 - 18 October 2009, vol.20
2008
200867. S1293 Is There a Role for Adipocytokines On the Effect of Anti TNF Treatment in An Experimental Model of Colitis
YAPALI S., DENİZ M., EREN F., İMERYÜZ N., ÇELİKEL Ç., ÖZKAN N., et al.
GASTROENTEROLOGY, 1 - 30 April 2008, vol.134, pp.219-220
2008
200868. P171 DOES INTESTINAL INFLAMMATION TRIGGER OXIDATIVE STRESS IN EXTRACOLONIC TISSUES
YAPALI S., DENİZ M., EREN F., İMERYÜZ N., ÇELİKEL Ç., ÖZKAN N., et al.
JOURNAL OF CROHN'S AND COLITIS SUPPLEMENTS, 1 - 29 February 2008, vol.2, pp.56
2008
200869. P271 DOES SUBCUTANEOUS FAT TISSUE CONTRIBUTE TO THE RELEASE OF ADIPOCYTOKINES IN INTESTINAL INFLAMMATION AS WELL AS MESENTERIC ADIPOSE TISSUE
YAPALI S., EREN F., DENİZ M., İMERYÜZ N., ÇELİKEL Ç., ÖZKAN N., et al.
JOURNAL OF CROHN'S AND COLITIS SUPPLEMENTS, 1 - 29 February 2008, vol.2
2007
200770. Deneysel intestinal inflamasyonda kolon dışı dokularda oksidatif hasar tetiklenir mi
YAPALI S., DENİZ M., EREN F., İMERYÜZ N., ÇELİKEL Ç., ÖZKAN N., et al.
24. Ulusal Gastroenteroloji Haftası, Nevşehir, Turkey, 16 - 21 October 2007, vol.18, pp.55
2007
200771. Adipositokinlerin deneysel intestinal inflamasyon modelinde ve anti TNF tedavi sonrasında inflamasyon sürecine etkisi
YAPALI S., İMERYÜZ N., EREN F., DENİZ M., ÇELİKEL Ç., ÖZKAN N., et al.
24. Ulusal Gastroenteroloji Haftası, Nevşehir, Turkey, 16 - 21 October 2007, vol.18, pp.20
2007
200772. Romatoid Artritte anti TNF tedavi sonrası iyi yanıt on gorulebilir mi
YAPALI S., İNANÇ G. N., AYDIN F., DİRESKENELİ R. H.
8. Ulusal Romatoloji Kongresi, Fethiye, Turkey, 5 - 07 September 2007
2007
200773. Astımda allerjik rinit ve diğer semptomların sıklığı
YAPALI S., CEYHAN B., ERYÜKSEL E., YILDIRIM F.
Türk Toraks Derneği 10. Yıllık Kongresi, Turkey, 25 - 29 April 2007, vol.8, pp.181
2006
200674. Fertility pregnancy nursing and sexual health in inflammatory bowel disease
YAPALI S., KEFELİ U., TAHAN V., BARGHI I., İMERYÜZ N., HAMZAOĞLU H., et al.
IBD 2007-Achievements in Research and Clinical Practice, 4 - 05 May 2006
2005
200575. Endoskopik kolangiopankreotografi ERCP taşıyıcılarda Salmonella kolesistitini tetikler mi
YAPALI S., GİRAL A., TİFTİKÇİ A., İMERYÜZ N., TÖZÜN A. N., KALAYCI C.
22. Ulusal Gastroenteroloji Haftası, Malatya, Turkey, 30 August - 04 September 2005, vol.16, pp.145
2005
200576. Böbrek naklinden 6 ay sonra gelişen bir gastrik lenfoma olgusu Ebstein Barr virüsün rolü
YAPALI S., TİFTİKÇİ A., ATAKAN A., BİRTAŞ ATEŞOĞLU E., İMERYÜZ N., TUĞLULAR Z. S., et al.
22. Ulusal Gastroenteroloji Haftasi, Turkey, 30 August - 04 September 2005, vol.16
Books
2012
20121. Gastrointestinal Kökenli Göğüs Ağrıları
YAPALI S., BOR S.
in: GÖĞÜS AĞRILI HASTAYA YAKLAŞIM EGE TIP AYIN KİTABI, Prof. Dr. Mehdi Zoghi, Editor, Ege Üniversitesi Tıp Fakültesi, İzmir, pp.41-72, 2012
Funded Projects
2024 - 2025
2024 - 2025Safra Kesesi Taşı Bulunan ve Bulunmayan Hastalar Arasındaki Mikrobiyom Farklılıkların Belirlenmesi ve Safra Kesesi Taşı Oluşumuna Etki Eden Biyomarkerların Tespit Edilmesi
Project Supported by Higher Education Institutions , BAP Research Project
YAPALI S. (Executive), KARA V., İşgördü Ö. H., Karaman T., AYGÜN C., TÖZÜN A. N., et al.
2020 - 2022
2020 - 2022REAL-LIfe Efficacy and TolerabilitY of Tenofovir alafenamide fumarate (TAF) in special groups of Hepatitis B patients: An Investigator-sponsored Clinical Trial Study: REALITY
Other International Funding Programs
(Project Abstract)
Yapalı S. (Executive), Idilman R.(Executive), Gökcan ., Dinçer D.(Executive), Gündüz F.
2020 - 2021
2020 - 2021Gastrointestinal symptoms of Sars-Cov-2 infection: a prospective multicentre study
Universities of Other Countries Supported Project
(Project Abstract)
Yapalı S., Bor S., Barbara G.
Activities in Scientific Journals
2022 - Continues
2022 - ContinuesTURKISH JOURNAL OF GASTROENTEROLOGY
Assistant Editor/Section Editor
2020 - Continues
2020 - ContinuesHepatology Forum
Assistant Editor/Section Editor
Memberships and Roles in Scientific Organizations
2025 - Present
2025 - PresentTurkish Association for The Study of Liver (TASL)
Secretary General
2023 - Continues
2023 - ContinuesEuropean Association for The Study of Liver (EASL) Hepatitis B Guideline Delphi Panel Member
Member of Advisory Board
2023 - Continues
2023 - ContinuesWorld Gastroenterology Organization Hepatology Committee Hepatitis B guideline Development
Member of Science Committee
2022 - Continues
2022 - ContinuesWorld Gastroenterology Organization Hepatology Committee
Member of Science Committee
2021 - Continues
2021 - ContinuesEuropean Association fot The Study of Liver
Member
Peer Reviews in Scientific Publications
January 2021
January 2021HEPATOLOGY FORUM
Other journals
January 2021
January 2021TURKISH JOURNAL OF GASTROENTEROLOGY
Journal Indexed in SCI-E
Roles in Event Organizations
June 2022
June 20229. Hepatoloji Okulu ‘’Akut Karaciğer Yetmezliği ve Karaciğer Transplantasyonu’’
Scientific Congress
Yapali S.
İzmir, Turkey
May 2019
May 201912. ULUSAL HEPATOLOJİ KONGRESİ - KARACİĞER HASTALIKLARINDA TARTIŞMALI VAKALAR VE KONULAR KURSU
Scientific Congress
Yapalı S., Akarca U. S.
Antalya, Turkey
Congress and Symposium Activities
15 May 2025 - 18 May 2025
15 May 2025 - 18 May 202516. Ulusal Hepatoloji Kongresi
Invited Speaker
Ankara-Turkey
24 April 2025 - 26 April 2025
24 April 2025 - 26 April 2025APASL STC New Treatments in Liver Cirrhosis
Invited Speaker
İstanbul-Turkey
26 November 2024 - 01 December 2024
26 November 2024 - 01 December 202441. Ulusal Gastroenteroloji Haftası
Invited Speaker
Antalya-Turkey
07 November 2024 - 09 November 2024
07 November 2024 - 09 November 202410th Congress of Croatian Society of Gastroenterology
Invited Speaker
Dubrovnik-Croatia
06 September 2024 - 07 September 2024
06 September 2024 - 07 September 2024GASTROENTEROLOGY SUMMIT ISTANBUL
Invited Speaker
İstanbul-Turkey
09 May 2024 - 11 May 2024
09 May 2024 - 11 May 202415th National Hepatology Congress
Invited Speaker
Rize-Turkey
01 March 2024 - 02 March 2024
01 March 2024 - 02 March 2024Ege Üniversitesi Namık Kemal Menteş Gastroenteroloji Günleri
Invited Speaker
İzmir-Turkey
16 February 2024 - 17 May 2024
16 February 2024 - 17 May 2024AASLD-TASL Hepatology Connect Meeting
Moderator
İzmir-Turkey
14 February 2024 - 15 February 2024
14 February 2024 - 15 February 2024AASLD-TASL Hepatology Connect Meeting
Invited Speaker
İstanbul-Turkey
21 November 2023 - 26 November 2023
21 November 2023 - 26 November 202340th National Gastroenterology Congress
Panelists
Antalya-Turkey
21 November 2023 - 26 November 2023
21 November 2023 - 26 November 202340th National Gastroenterology Congress
Moderator
Antalya-Turkey
17 April 2023 - 17 April 2023
17 April 2023 - 17 April 2023Pregnancy and Liver Disease: Navigating the Complexities on a Global Scale
Invited Speaker
Wisconsin-United States Of America
18 January 2023 - 18 January 2023
18 January 2023 - 18 January 2023TKAD Mezuniyet Sonrası Eğitim Toplantısı
Invited Speaker
İstanbul-Turkey
22 November 2022 - 27 November 2022
22 November 2022 - 27 November 202239. Ulusal Gastroenteroloji Haftası
Invited Speaker
Antalya-Turkey
01 October 2022 - 01 October 2022
01 October 2022 - 01 October 2022TKAD Mezuniyet Sonrası Eğitim Toplantısı
Invited Speaker
Diyarbakır-Turkey
23 September 2022 - 25 September 2022
23 September 2022 - 25 September 2022APASL 2022 Single Topic Conference on Hepatotoxicity
Invited Speaker
İstanbul-Turkey
22 September 2022 - 22 September 2022
22 September 2022 - 22 September 2022The Global Burden of Hepatitis B- Webinar Series-Breakthroughs in Hepatitis B
Invited Speaker
Wisconsin-United States Of America
29 June 2022 - 29 June 2022
29 June 2022 - 29 June 2022TKAD İstanbul Şubesi Aylık Toplantısı- EASL 2022 ve DDW 2022'den Seçmeler
Invited Speaker
İstanbul-Turkey
10 June 2022 - 12 June 2022
10 June 2022 - 12 June 20229. Hepataloji Okulu
Invited Speaker
İzmir-Turkey
17 March 2022 - 19 April 2022
17 March 2022 - 19 April 2022Anadolu Gastroenteroloji Günleri
Invited Speaker
Şanlıurfa-Turkey
15 January 2022 - 15 January 2022
15 January 2022 - 15 January 2022AASLD TASL Digital Hepatology Meeting
Panelists
İstanbul-Turkey
14 January 2022 - 15 January 2022
14 January 2022 - 15 January 2022AASLD TASL Digital Hepatology Meeting
Invited Speaker
İstanbul-Turkey
16 November 2021 - 21 November 2021
16 November 2021 - 21 November 202138. Ulusal Gastroenteroloji Haftası
Invited Speaker
Antalya-Turkey
08 November 2021 - 08 November 2021
08 November 2021 - 08 November 2021Nörogastroenteroloji ve Motilite Çalışma Grubu Aylık Toplantısı
Invited Speaker
İstanbul-Turkey
22 October 2021 - 24 October 2021
22 October 2021 - 24 October 2021FBH Akademi
Invited Speaker
Girne-Cyprus (Kktc)
16 September 2021 - 19 September 2021
16 September 2021 - 19 September 202110. Ulusal Sağlıklı Yaşam Kongresi
Invited Speaker
İstanbul-Turkey
13 July 2021 - 13 July 2021
13 July 2021 - 13 July 2021Türkiye Klinikleri TV
Invited Speaker
İstanbul-Turkey
30 June 2021 - 30 June 2021
30 June 2021 - 30 June 2021Vemlidy Gerçek Yaşam Zirvesi
Invited Speaker
İstanbul-Turkey
12 March 2021 - 13 March 2021
12 March 2021 - 13 March 2021TASL BASL Joint Meeting
Invited Speaker
İstanbul-Turkey
Citations
Total Citations (SCOPUS): 351
h-index (SCOPUS): 10
Jury Memberships
August-2022
August 2022Doctoral Examination
Tıpta Uzmanlık Sınavı - Acibadem Mehmet Ali Aydinlar University
July-2022
July 2022Expertise In Medicine
Tez Jürisi - Acibadem Mehmet Ali Aydinlar University
January-2022
January 2022Committee Of Expert
World Gastroenterology Organization, Hepatology Committee Member - World Gastroenterology Organization
Scientific Research / Working Group Memberships
2021 - Continues
2021 - ContinuesWgo Hepatology Special Interest Group
https://www.worldgastroenterology.org/who-we-are/organization/committees-interest-groups/hepatology-interest-group
World Gastroenterology Organization, United States Of America
2019 - Continues
2019 - ContinuesViral Hepatitis Special Interest Group
https://www.tkad.org.tr/viral-hepatit/
Acibadem Mehmet Ali Aydinlar University, Turkey
2019 - Continues
2019 - Continues